Folate Receptor Alpha (FOLR1) – Function & Cancer
Folate receptor alpha (FOLR1) is a cell-surface protein that binds and transports folate (vitamin B9) into cells. It is a key target in cancer research and oncology.
Things worth knowing about "Folate receptor alpha"
Folate receptor alpha (FOLR1) is a cell-surface protein that binds and transports folate (vitamin B9) into cells. It is a key target in cancer research and oncology.
What is Folate Receptor Alpha?
Folate receptor alpha (also known as FOLR1) is a specialized transport protein located on the surface of certain cells in the body. Its primary function is to bind folate (vitamin B9) from the bloodstream and transport it into the interior of the cell. Folate is an essential vitamin required for cell division, DNA synthesis, and cell growth.
Under normal conditions, FOLR1 is expressed only in a limited number of specific tissues, such as the kidneys, lungs, and placenta. However, the receptor has gained considerable medical significance because it is found in greatly elevated amounts on the surface of many cancer cells.
Biological Function
Folate is indispensable for all dividing cells, as it serves as a coenzyme in the synthesis of nucleotides – the building blocks of DNA. Folate receptor alpha enables cells to efficiently take up folate even at low concentrations in the blood. The mechanism by which this occurs is called receptor-mediated endocytosis: the receptor binds folate, is drawn into the cell, and releases the folate inside.
Significance in Oncology
Cancer cells have a particularly high demand for folate because they divide uncontrollably and very rapidly. Many tumors address this need by producing large amounts of folate receptor alpha on their cell surface (overexpression). This overexpression is especially common in:
- Ovarian carcinoma – in up to 90% of cases
- Non-squamous cell lung carcinoma
- Endometrial carcinoma (uterine cancer)
- Triple-negative breast cancer
- Mesothelioma
Since healthy tissue rarely expresses the receptor, FOLR1 represents an attractive target for precision cancer therapies.
FOLR1 as a Therapeutic Target
The overexpression of folate receptor alpha on tumor cells is actively exploited in modern oncology to deliver cancer drugs as precisely as possible to the tumor while sparing healthy tissue. The most important therapeutic approaches include:
Antibody-Drug Conjugates (ADC)
In this form of therapy, an antibody that specifically binds to FOLR1 is linked to a cytotoxic agent (a cell-killing drug). The conjugate attaches selectively to the tumor cell, is internalized, and releases the cell-damaging agent inside. One example is Mirvetuximab Soravtansin, which is approved for the treatment of FOLR1-positive ovarian carcinoma.
Monoclonal Antibodies
Monoclonal antibodies can bind to FOLR1 and thereby inhibit tumor cell growth or activate the immune system to destroy the cancer cells.
CAR-T Cell Therapy
Researchers are also developing CAR-T cells (genetically modified immune cells) designed to recognize FOLR1 on tumor cells and attack them specifically.
Folate Conjugates
In this approach, therapeutic agents or imaging substances are directly coupled to the folate molecule. Because folate receptor alpha binds folate with high affinity, such conjugates are selectively taken up by tumor cells. This principle is also used in diagnostics, for example in folate receptor scintigraphy.
Diagnostic Significance
Determining FOLR1 expression in tumor tissue is now an important step in treatment planning. Through immunohistochemistry (staining of tissue samples) or molecular analyses, it can be established whether a tumor overexpresses FOLR1 and whether a patient may benefit from a FOLR1-targeted therapy. FOLR1 testing is therefore referred to as biomarker diagnostics.
Safety and Side Effects of FOLR1-Targeted Therapies
Because folate receptor alpha is also present in some healthy tissues (e.g., renal tubule cells), FOLR1-targeted therapies may occasionally cause side effects in these areas. Possible side effects include:
- Ocular changes (keratopathy, visual disturbances) – particularly with ADCs
- Nausea, vomiting, diarrhea
- Fatigue
- Peripheral neuropathy (nerve pain in the hands and feet)
These side effects are carefully monitored in clinical trials and managed with supportive measures.
References
- Vergote I et al. - Mirvetuximab Soravtansin in FOLR1-Positive, Platinum-Resistant Ovarian Cancer. New England Journal of Medicine, 2023.
- Leamon CP, Reddy JA - Folate-targeted chemotherapy. Advanced Drug Delivery Reviews, 2004; 56(8):1127-1141.
- National Cancer Institute (NCI) - Folate Receptor Alpha as a Target for Cancer Therapy. cancer.gov, 2023.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.